NCT07023289 · Interventional trial
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Overall registry status Recruiting
Phase 2
Conditions Colorectal Cancer
Delaware Valley sites
- University of Pennsylvania - Perelman Center for Advanced Medicine /ID# 275407 · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory